MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells

Figure 5

MiR-522-3p facilitated GC cell resistance to DDP via targeting TCF4. (a) Colony formation assessed AGS and AGS/DDP cell proliferation after indicated treatment. (b) Flow cytometry evaluated AGS and AGS/DDP cell apoptosis after indicated treatment.  < 0.01,  < 0.001, miR-522-3p vs. NC mimics group; ^## < 0.01, ^### < 0.001, miR-522-3+TCF4 vs. miR-522-3p group.

(a)

(b)